CIK 0001479419
- Non-accelerated filer
- Smaller reporting company
KALA BIO, Inc.
Sign in to watch- Ticker
- KALA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 270604595
- Phone
- +1 781-996-5252
- Business address
- 1167 MASSACHUSETTS AVENUE, ARLINGTON, MA, 02476
- Former names
- KALA BIO, Inc., Kala Pharmaceuticals, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 46 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-06-25 | KOVEN ANDREW I Director | Grant or award | +28,000 | 28,000 | ||
| 2020-06-25 | Chen Hongming Chief Scientific Officer | Grant or award | +16,000 | 102,849 | ||
| 2020-06-25 | Bazemore Todd Chief Operating Officer | Grant or award | +19,000 | 29,000 | ||
| 2020-06-19 | Trachtenberg Eric | Exercise or conversion | +28,901 | $5.19 | $150K | 28,901 |
| 2020-06-19 | Trachtenberg Eric | Exercise or conversion · Stock Option (right to buy) | −28,901 | 136,099 | ||
| 2020-06-09 | Reumuth Mary Chief Financial Officer | Exercise or conversion | +11,520 | $2.30 | $26K | 16,336 |
| 2020-06-09 | Reumuth Mary Chief Financial Officer | Exercise or conversion | +5,077 | $5.21 | $26K | 21,413 |
| 2020-06-09 | Reumuth Mary Chief Financial Officer | Exercise or conversion | +15,360 | $2.30 | $35K | 36,773 |
| 2020-06-09 | Reumuth Mary Chief Financial Officer | Exercise or conversion | +11,520 | $2.30 | $26K | 48,293 |
| 2020-06-09 | Reumuth Mary Chief Financial Officer | Exercise or conversion · Stock Option (right to buy) | −11,520 | 0 | ||
| 2020-06-09 | Reumuth Mary Chief Financial Officer | Exercise or conversion · Stock Option (right to buy) | −5,077 | 0 | ||
| 2020-06-09 | Reumuth Mary Chief Financial Officer | Exercise or conversion · Stock Option (right to buy) | −15,360 | 0 | ||
| 2020-06-09 | Reumuth Mary Chief Financial Officer | Exercise or conversion · Stock Option (right to buy) | −11,520 | 0 | ||
| 2020-06-05 | Bazemore Todd Chief Operating Officer | Purchase | +2 | $13.39 | $27 | 2 |
| 2020-04-09 | Brazzell Romulus K Chief Medical Officer | Exercise or conversion | +1,880 | $0.68 | $1K | 110,605 |
| 2020-04-09 | Brazzell Romulus K Chief Medical Officer | Exercise or conversion | +18,247 | $2.30 | $42K | 128,852 |
| 2020-04-09 | Brazzell Romulus K Chief Medical Officer | Exercise or conversion | +47,644 | $3.34 | $159K | 176,496 |
| 2020-04-09 | Brazzell Romulus K Chief Medical Officer | Exercise or conversion · Stock Option (right to buy) | −1,880 | 0 | ||
| 2020-04-09 | Brazzell Romulus K Chief Medical Officer | Exercise or conversion · Stock Option (right to buy) | −18,247 | 0 | ||
| 2020-04-09 | Brazzell Romulus K Chief Medical Officer | Exercise or conversion · Stock Option (right to buy) | −47,644 | 13,508 |
Page 17 of 19 · 378 trades